Equibles does not estimate personal net worth.
Get an email with a short summary when Iovance Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IOVA alertsRaj Khoury has spoken on 1 earnings call across 1 company, most recently for Iovance Biotherapeutics, Inc. on November 5, 2026. Iovance Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Iovance Biotherapeutics, Inc. includes Frederick G. Vogt, Ph.D. (CEO), Frederick Vogt (CEO and General Counsel), Corleen Roche (CFO) and 7 others.
“Yes, I agree with Fred's comment that the FDA, we are on track to get VLA from Nathan to end And based on our data, we are confident that FDA will consider the accelerated approval based on the prior approvals in this space with about 80 subjects' trials.”
Transcript header (unverified)
Biotechnology · Healthcare
